BE730345A - - Google Patents
Info
- Publication number
- BE730345A BE730345A BE730345DA BE730345A BE 730345 A BE730345 A BE 730345A BE 730345D A BE730345D A BE 730345DA BE 730345 A BE730345 A BE 730345A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB06113/68A GB1218591A (en) | 1968-04-03 | 1968-04-03 | Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE730345A true BE730345A (es) | 1969-09-21 |
Family
ID=10071423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE730345D BE730345A (es) | 1968-04-03 | 1969-03-24 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3634411A (es) |
| BE (1) | BE730345A (es) |
| BG (1) | BG15397A3 (es) |
| CH (1) | CH498845A (es) |
| CS (1) | CS163733B2 (es) |
| DK (1) | DK123824C (es) |
| FI (1) | FI51190C (es) |
| FR (1) | FR2007372A1 (es) |
| GB (1) | GB1218591A (es) |
| IL (1) | IL31901A (es) |
| IT (1) | IT1036019B (es) |
| LU (1) | LU58316A1 (es) |
| NL (1) | NL147427B (es) |
| NO (1) | NO124312B (es) |
| RO (1) | RO55704A (es) |
| SE (1) | SE351212B (es) |
| YU (1) | YU33015B (es) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
| WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
| WO2007105050A1 (en) | 2006-03-10 | 2007-09-20 | Pfizer Products Inc. | Dibenzyl amine compounds and derivatives |
| WO2007105049A1 (en) | 2006-03-10 | 2007-09-20 | Pfizer Products Inc. | Dibenzyl amine derivatives as cetp inhibitors |
| WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
| WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2092703A1 (en) * | 1970-06-10 | 1972-01-28 | Delalande Sa | 2-(1-pyrrolidinocarbonylmethyl-piperazin-4-yl) ethyl - 3,4,5-trimethoxy benzoate - having hypotensive and adrenolytic active |
| FR2092902A1 (en) * | 1970-06-30 | 1972-01-28 | Delalande Sa | Substd propiophenone - beta (pyrrolidino carbonylmethyl)-1'-piperazin propiophenones, analgesics, hypotensives adrenolytics, noradrenolytic |
| FR2278340A1 (fr) * | 1974-07-17 | 1976-02-13 | Delalande Sa | Nouveau derive de la n-(trimethoxy-3,4,5 cinnamoyl) piperazine, ses sels d'addition d'acides, son procede de preparation et son application en therapeutique |
| GB1473262A (en) * | 1974-11-20 | 1977-05-11 | Delalande Sa | Derivatives of n-3,4,5-trimethoxy cinnamoyl-piperazine their process of preparation and their therapeutic application |
| GR71991B (es) * | 1980-01-21 | 1983-08-26 | Delalande Sa | |
| JPS5888370A (ja) * | 1981-11-19 | 1983-05-26 | Hokuriku Seiyaku Co Ltd | １−（３，４，５−トリメトキシシンナモイル）−４−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体、及びその製造方法 |
| IT1151104B (it) * | 1982-02-04 | 1986-12-17 | Delalande Sa | Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici |
| FR2522325B1 (fr) * | 1982-02-26 | 1985-08-09 | Delalande Sa | Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique |
| FR2552762B1 (fr) * | 1983-09-30 | 1986-07-25 | Delalande Sa | Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique |
| JPS6172773A (ja) * | 1984-09-17 | 1986-04-14 | Terumo Corp | ピペラジン誘導体およびこれを含有する血管拡張剤 |
| US6011035A (en) * | 1998-06-30 | 2000-01-04 | Neuromed Technologies Inc. | Calcium channel blockers |
| US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
| US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| JP2010533672A (ja) | 2007-07-19 | 2010-10-28 | エフ．ホフマン−ラ ロシュ アーゲー | 新規ヘテロシクリル化合物およびケモカインアンタゴニストとしてのそれらの使用 |
| CN101260092B (zh) * | 2008-04-14 | 2011-07-20 | 罗军 | 马来酸桂哌齐特的制备方法 |
| CN101723918B (zh) * | 2008-10-24 | 2011-08-31 | 重庆医科大学医药研究所 | 马来酸桂哌齐特的制备工艺 |
| CN101531643B (zh) * | 2009-04-13 | 2012-11-14 | 上海理奥生物医药科技有限责任公司 | 一种改进的马来酸桂哌齐特的合成方法 |
| CN102229583B (zh) * | 2011-05-13 | 2013-11-27 | 江苏神龙药业有限公司 | 一种桂哌齐特的合成方法 |
| CN103664830A (zh) * | 2012-09-05 | 2014-03-26 | 凌沛学 | 一种马来酸桂哌齐特改进的合成方法 |
| CN103896878B (zh) * | 2012-12-26 | 2018-02-09 | 江苏万邦生化医药股份有限公司 | 一种桂哌齐特的纯化脱色方法 |
| CN103245734A (zh) * | 2013-01-18 | 2013-08-14 | 沈阳亿灵医药科技有限公司 | 一组控制马来酸桂哌齐特质量的组合物 |
-
1968
- 1968-04-03 GB GB06113/68A patent/GB1218591A/en not_active Expired
-
1969
- 1969-03-24 BE BE730345D patent/BE730345A/xx not_active IP Right Cessation
- 1969-03-25 IL IL31901A patent/IL31901A/xx unknown
- 1969-03-26 CH CH460069A patent/CH498845A/fr not_active IP Right Cessation
- 1969-03-26 LU LU58316D patent/LU58316A1/xx unknown
- 1969-03-31 DK DK176769AA patent/DK123824C/da not_active IP Right Cessation
- 1969-04-01 BG BG011961A patent/BG15397A3/bg unknown
- 1969-04-01 NL NL696905019A patent/NL147427B/xx not_active IP Right Cessation
- 1969-04-01 FR FR6909764A patent/FR2007372A1/fr active Pending
- 1969-04-01 US US812369A patent/US3634411A/en not_active Expired - Lifetime
- 1969-04-02 RO RO59598A patent/RO55704A/ro unknown
- 1969-04-02 SE SE04761/69A patent/SE351212B/xx unknown
- 1969-04-03 YU YU834/69A patent/YU33015B/xx unknown
- 1969-04-03 CS CS2408A patent/CS163733B2/cs unknown
- 1969-04-03 FI FI690996A patent/FI51190C/fi active
- 1969-04-03 IT IT51301/69A patent/IT1036019B/it active
- 1969-10-03 NO NO1388/69*[A patent/NO124312B/no unknown
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
| EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
| WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
| WO2007105050A1 (en) | 2006-03-10 | 2007-09-20 | Pfizer Products Inc. | Dibenzyl amine compounds and derivatives |
| WO2007105049A1 (en) | 2006-03-10 | 2007-09-20 | Pfizer Products Inc. | Dibenzyl amine derivatives as cetp inhibitors |
| WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| US3634411A (en) | 1972-01-11 |
| NO124312B (es) | 1972-04-04 |
| FI51190B (es) | 1976-08-02 |
| DE1915795B2 (de) | 1975-07-03 |
| IL31901A0 (en) | 1969-05-28 |
| IT1036019B (it) | 1979-10-30 |
| FI51190C (fi) | 1976-11-10 |
| BG15397A3 (bg) | 1976-05-26 |
| YU33015B (en) | 1976-03-31 |
| SE351212B (es) | 1972-11-20 |
| LU58316A1 (es) | 1969-10-27 |
| DK123824B (es) | 1972-08-07 |
| FR2007372A1 (es) | 1970-01-09 |
| CH498845A (fr) | 1970-11-15 |
| NL147427B (nl) | 1975-10-15 |
| YU83469A (en) | 1975-06-30 |
| NL6905019A (es) | 1969-10-07 |
| GB1218591A (en) | 1971-01-06 |
| DK123824C (da) | 1972-12-18 |
| DE1915795A1 (de) | 1970-09-10 |
| IL31901A (en) | 1972-03-28 |
| RO55704A (es) | 1974-01-03 |
| CS163733B2 (es) | 1975-11-07 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: DELALANDE S.A. Effective date: 19890324 |